CVS Jumping on Cost-plus Bandwagon
Pharmacy benefit managers have been under pressure to simplify their complicated, obscure pricing tactics.
CVS Health is joining pharmacy benefit managers by offering simpler, cost-plus pricing, although it won't be available until 2025.
“CVS CostVantage will define the drug cost and related reimbursement with contracted pharmacy benefit managers (PBMs) and payers, using a transparent formula built on the cost of the drug, a set markup, and a fee that reflects the care and value of pharmacy services,” the company said in a news release this morning in advance of its investor’s day event.
CVS Pharmacy plans to launch CVS CostVantage with PBMs for their commercial payers in 2025, according to the news release.
The news release also announced the launch of a program called TrueCost, which the company will offer “client pricing reflecting the true net cost of prescription drugs, with visibility into administrative fees.” It will also be available in 2025.
Cigna Group’s Express Scripts announced plans to offer a “cost-plus” drug pricing model in November.
Pharmacy benefit managers (PBMs) especially the ‘big three” — CVS Caremark, Express Scripts and Optum Rx — have been under pressure to make their complicated, often obscure pricing tactics more transparent. Mark Cuban, the owner of the NBA’s Dallas Mavericks and a “Shark Tank” judge, co-founded Mark Cuban Cost Plus Drugs in early 2022 with a simple mark-up pricing strategy that Express Scripts and CVS Caremark appear to be emulating.
Several PBM reform bills have been introduced in Congress that would also require more reporting and transparency.
Optimize Your Healthcare Payments with Optum Financial
April 29th 2025Discover how Optum Financial is revolutionizing healthcare payments in our latest whitepaper. Learn how transitioning to electronic payments can reduce administrative costs, streamline claims processing and enhance security.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Healthcare hasn't been a priority of the second Trump administration so far, panelists at the Asembia agreed. Medicaid may loom large, though, as the administration and congressional Republicans look for ways to slash government spending as a way of offsetting major tax cuts.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
What 5 Managed Care Trends Experts Say You’re Not Watching Closely Enough
April 29th 2025Managed Healthcare Executive asked several experts in healthcare and managed care two share the trends they think the industry is overlooking. From rising costs and data challenges to shifts in how care is delivered, these are the issues that could have a major impact — and deserve a closer look.
Read More
